Red Cat Holdings, Inc. focuses on advanced drone and robotic systems for defense and national security applications. Its subsidiaries, including Teal Drones, FlightWave Aerospace, and the Blue Ops maritime unit, deliver hardware and software for military, government, and public-safety use across air, land, and sea domains.
Core offerings center on the Black Widow small unmanned aircraft system along with platforms such as the Hellcat, Edge 130, and TRICHON vertical takeoff and landing system, plus uncrewed surface vessels from Blue Ops. The company supports the U.S. Army Short Range Reconnaissance program and works with international customers including NATO allies and Japan. I find the stock noteworthy given its positioning in rising defense budgets for autonomous systems, domestic production capacity, and the push to broaden beyond aerial drones into a multi-domain autonomy provider. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
From a closing price near $6.46 on September 30, 2026, RCAT shares moved down to approximately $4.63 by October 30, 2026, for a decline of roughly 28%. The drop unfolded gradually rather than in one sharp session, with several higher-volume selling days throughout the period.
Over the trailing quarter the picture was comparable in scale. Starting from a late-July 2026 close around $7.38, the stock fell about 37% through the end of October. An earlier spike toward $11 in mid-August reversed quickly, highlighting the share price’s volatility and its reaction to shifting views on the defense-technology group. By the close of the period, shares sat near multi-month lows.
The October 19 announcement of a proposed cash offer to acquire Steyr Motors AG at €39.00 per share, valuing the Austrian firm at roughly €205 million, stood out as the clearest driver. Management positioned the deal as supportive of the Blue Ops maritime strategy, yet investors focused on financing needs and possible share dilution.
Analyst sentiment turned more cautious as well. On October 23, Piper Sandler cut its price target to $6 from $9, referencing “tremendous selling pressure” in the defense sector and a shift “from budgetary exuberance to budgetary austerity.” Other notes during the window flagged dilution risk and execution questions tied to the Steyr Motors transaction, while reported insider selling added to the tone. A broader rotation out of high-multiple defense names added further weight.
The larger three-month drop reflected a sector-wide repricing more than any single company event. Early enthusiasm around defense budgets and autonomous systems had lifted RCAT toward $11 in mid-August before momentum faded as investors became more selective with pre-profit growth names.
Second-quarter fiscal 2026 results, released in August, showed revenue of about $20.2 million that missed consensus estimates even as management reiterated the $150 million–$180 million full-year target. Higher operating costs tied to production scale-up and the implied steep second-half ramp left the market questioning near-term delivery. The late-October Steyr Motors news then shifted attention to balance-sheet and integration issues, extending the downward move.
The upcoming third-quarter fiscal 2026 earnings release in mid-November 2026 stands as the clearest near-term catalyst. Focus will likely fall on revenue growth, margin trends, and any update to the annual revenue guidance that implies significant second-half acceleration. Progress on the Steyr Motors transaction, including approvals and financing details, will also draw attention given ongoing dilution concerns.
Sector-level budget commentary, contract awards, competitive dynamics in small-drone and uncrewed-surface-vessel markets, supply-chain execution, and the pace of international orders remain additional factors worth following. These points are for informational purposes only and do not constitute investment advice or performance predictions.
In my own research process I frequently review Tickeron’s AI Trading Bots to observe how different automated strategies are positioned around volatile names like RCAT. The platform surfaces top-performing bots across strategies and timeframes, giving a structured view of real-time momentum that complements traditional fundamental work. This helps me cross-check sentiment signals without replacing core analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
RCAT saw its Momentum Indicator move below the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In 70 of the 82 cases, the stock moved further down in the following days. The odds of a decline are at 85%.
The Moving Average Convergence Divergence Histogram (MACD) for RCAT turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 34 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for RCAT entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +32.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCAT advanced for three days, in 233 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
RCAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.309) is normal, around the industry mean (5.050). P/E Ratio (-5.050) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (11.820) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. RCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense